Healthcare company Progressive Care (OTC PINK:RXMD) announced on Thursday that it achieved record breaking revenues of USD1.5m for March.
This revenue collection marks an improvement of 45% over March 2015 and nearly USD100,000 more than the last record breaking month in December 2015.
The company added that it broke its all-time sales records during March, filling approximately 18,600 prescriptions, up 36% over the same month last year and about 1,400 more prescriptions filled from the last highest month in September 2015.
In March 2016, the company began developing and marketing its own compound version of generic Viagra known as Sildenafil/Oxytocin. It is currently compounding the drug in a number of dosage forms including capsules and sublingual sprays.
Eli Lilly announces Q1 2026 dividend
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government